Long-term follow-up of tislelizumab combined with anlotinib in a single patient with metastatic type B3 thymoma: a case report - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Extended Observation of Tislelizumab and Anlotinib Combination Therapy in a Patient with Metastatic Type B3 Thymoma: A Case Study

  • By

  • Ting Jiang

  • Chen Gao

  • Fangmi Ding

  • Shuyi Chen

  • Qunwei Chen

  • August 19, 2026

Share

Original Source(s)

Related Content